Cooper University Health Care is the first health system in South Jersey to offer a new diagnostic test to detect recurrent prostate cancer earlier. Axumin is an FDA-approved scan that can achieve early detection of recurrent prostate cancer following surgery or radiation.
“While prostate cancer is consistently one of the top three cancers in the nation, there have been very few effective advances in imaging for this disease,” said Robert A. Read more.